Vergoeding 2019-2023 voor ATC-subgroep B01A : Antithrombotica
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| B01AA Vitamine k-antagonisten | 3.659.900 | 3.347.000 | 3.210.600 | 2.682.100 | 2.352.600 |
| B01AB Heparinegroep | 21.601.200 | 18.032.000 | 16.137.400 | 16.889.400 | 15.649.000 |
| B01AC Trombocytenaggregatieremmers excl heparine | 52.701.100 | 50.396.700 | 49.392.600 | 53.471.900 | 53.874.600 |
| B01AD Enzymen | . | 3.172 | 13.662 | 21.583 | 19.842 |
| B01AE Directe trombineremmers | 39.982.000 | 36.170.400 | 30.951.300 | 30.867.200 | 31.121.400 |
| B01AF Directe remmers van factor xa | 158.705.900 | 192.354.600 | 221.646.100 | 258.309.800 | 286.996.100 |
| B01AX Overige antithrombotica | 731.940 | 597.590 | 679.620 | 671.500 | 589.310 |
| Totaal | 277.382.040 | 300.901.462 | 322.031.282 | 362.913.483 | 390.602.852 |